SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today introduced the mRNA sequencing application on its C1™ Single-Cell Auto Prep System. With this new C1 system application, researchers have an easy, end-to-end workflow for detailed transcriptome analysis of 96 single cells to rapidly study differential expression profiles of diverse cell populations. The C1 mRNA Seq […]
Gaithersburg, Md.— OpGen, Inc. today announced the company has entered into a scientific and technical partnership with the University of California, Davis, (UC Davis) in cooperation with the FDA supported 100K Genome Project to create high resolution microbial genetic maps. The 100K Genome Project is a collaboration that was initiated by the U.S. Food and […]
PORT WASHINGTON, N.Y.,- Pall Corporation (NYSE: PLL) today announced that Lisa McDermott, Chief Financial Officer and Treasurer, will be leaving the Company effective March 10, 2013, in order to pursue other interests. While an external search is underway, Ms. McDermott will continue to serve the Company as CFO until her departure on March 10, 2013 […]
Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today its quality management system has received ISO 9001:2008 certification. The certification offers further reassurance to customers using the Gyros nanoliter-scale immunoassay platform that the products and services they receive are of a consistently high standard. The Gyros […]
The Genome Institute of Singapore (GIS), an institute under the umbrella of the Agency for Science, Technology and Research (A*STAR), and Fluidigm Corporation (NASDAQ:FLDM) today announced the establishment of the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through […]
PathoGenetix, Inc., a commercial-stage developer of an automated system for rapid identification and typing of bacteria strains, today announced that John W. Czajka, Ph.D., M.B.A. has joined the company as Vice President of Business Development. Dr. Czajka will coordinate the commercial application of the company’s proprietary Genome Sequence Scanning™ (GSS™) technology for food safety testing […]
SAN DIEGO, — Sequenom, Inc. (Nasdaq: SQNM) announced today the appointments of William Welch as the Company’s President and Chief Operating Officer and Dirk van den Boom as the Company’s Executive Vice President, Research & Development and Chief Technology Officer, both effective immediately. Additionally, Ronald Lindsay has been named as the Company’s Executive Vice President, […]
Accurate and fast validation of biomarkers; increasing efficiency in Research and Drug Development DMAT is an innovative and integrated detection platform for high quality biomarker analysis. It enables accelerated development of multiplex assays where several biomarkers can be analyzed at the same time. DMAT dramatically reduces hands-on time and allows users to perform bioassays far […]
Boulder, Colorado — BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC’s 23rd Annual Antibody Engineering and Therapeutics Conference in San Diego. The conference, which runs December 2 – 6, 2012, is one of the preeminent technology symposia in the world for the international antibody development and research community. “The […]
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced the completion of a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. All previous venture […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
